| 1 |
27568305 | Recombinant granulocyte colony-stimulating factor (rG-CSF) in the management of neutropenia induced by anthracyclines and ifosfamide in patients with soft tissue sarcomas (NEUSAR). | 2017 Jan |
1 |
| 2 |
28231491 | Effect of granulocyte colony-stimulating factor on outcomes in patients with non-M3 acute myelogenous leukemia treated with anthracycline-based induction (7+3 regimen) chemotherapies. | 2017 Jun |
2 |
| 3 |
24532305 | Retrospective analysis of the use of G-CSF and its impact on dose response for anthracycline plus taxane-based schedules in early breast cancer. | 2014 Sep |
2 |
| 4 |
16520664 | Weekly paclitaxel, 5-fluorouracil and folinic acid with granulocyte colony-stimulating factor support in metastatic breast cancer patients: a phase II study. | 2006 Mar |
2 |
| 5 |
15613908 | Biweekly docetaxel and vinorelbine with granulocyte colony-stimulating factor support for patients with anthracycline-resistant metastatic breast cancer. | 2005 Jan |
1 |
| 6 |
16020968 | Biweekly docetaxel-irinotecan treatment with filgrastim support is highly active in antracycline-Paclitaxel-refractory breast cancer patients. | 2005 |
1 |
| 7 |
15899616 | [Dose density and dose intensity in the treatment of breast cancer]. | 2004 Dec 1 |
1 |
| 8 |
12425755 | Phase III trial comparing granulocyte colony-stimulating factor to leridistim in the prevention of neutropenic complications in breast cancer patients treated with docetaxel/doxorubicin/cyclophosphamide: results of the BCIRG 004 trial. | 2002 Oct |
1 |
| 9 |
11110057 | Treatment of advanced, refractory breast cancer with alternating docetaxel and epirubicin/cyclophosphamide plus human granulocyte colony-stimulating factor. | 2000 Oct |
2 |
| 10 |
10358698 | FLAG (fludarabine, high-dose cytarabine, and G-CSF) for refractory and high-risk relapsed acute leukemia in children. | 1999 Jun |
1 |
| 11 |
9523740 | Effect of filgrastim on the pharmacokinetics of MX2 hydrochloride in patients with advanced malignant disease. | 1998 |
2 |
| 12 |
15989586 | Docetaxel: a new active agent in the therapy of metastatic breast cancer. | 1997 Dec |
2 |
| 13 |
7543699 | High-dose paclitaxel with granulocyte colony-stimulating factor in patients with advanced breast cancer refractory to anthracycline therapy: a European Cancer Center trial. | 1995 Aug |
1 |